Bacteriophages as potential antibiotic potentiators in cystic fibrosis: A new model to study the combination of antibiotics with a bacteriophage cocktail targeting dual species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa

被引:1
作者
Wang, Zhifen [1 ]
De Soir, Steven [1 ,2 ]
Glorieux, Antoine [1 ,2 ]
Merabishvili, Maya [2 ]
Knoop, Christiane [3 ]
De Vos, Daniel [2 ]
Pirnay, Jean-Paul [2 ]
Van Bambeke, Francoise [1 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmacol Cellulaire & Mol, Brussels, Belgium
[2] Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium
[3] Univ Libre Bruxelles, Erasme Hosp, Brussels, Belgium
关键词
Phages; Antibiotics; Cystic fibrosis; Dual-species biofilm; Staphylococcus aureus; Pseudomonas aeruginosa; SPUTUM;
D O I
10.1016/j.ijantimicag.2024.107276
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Staphylococcus aureus and Pseudomonas aeruginosa co-infections in patients with cystic fibrosis (CF) are associated with disease severity. Their treatment is complicated by biofilm formation in the sticky mucus obstructing the airways. We investigated the activity of phages-antibiotics combinations using a dual species biofilm ( P. aeruginosa/S. aureus ) formed in artificial sputum medium. Methods: Biofilmswere incubated with broad-spectrum antibiotics (meropenem, ceftazidime, ciprofloxacin, tobramycin) combined with a cocktail of two (bacterio)phages (PSP3 and ISP) proven active via spot tests and double agar on P. aeruginosa PAO1 and S. aureus ATCC 25923. Results: At the highest tested concentrations (100 x MIC), antibiotics alone caused a 20-50% reduction in biomass and reduced S. aureus and P. aeruginosa CFU of 2.3 to 2.8 and 2.1 to 3.6 log10 , respectively. Phages alone reduced biofilm biomass by 23% and reduced P. aeruginosa CFU of 2.1 log10 , but did not affect S. aureus viability. Phages enhanced antibiotic effects on biomass and exhibited additive effects with antibiotics against P. aeruginosa , but not against S. aureus. Following inhibition of bacterial respiration by phages in planktonic cultures rationalised these observations by demonstrating that PSP3 was effective at multiplicities of infection (MOI) as low as 10(-4) plaque forming units (PFU)/CFU on P. aeruginosa , but ISP, at higher MOI ( > 0.1) against S. aureus. Conclusion: Pre-screening inhibition of bacterial respiration by phages may assist in selecting those showing activity at sufficiently low titers to showcase anti-biofilm activity in this complex but clinicallyrelevant in vitro model of biofilm. (c) 2024 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:6
相关论文
共 28 条
[1]   Combining phages and antibiotic to enhance antibiofilm efficacy against an in vitro dual species wound biofilm [J].
Akturk, Ergun ;
Oliveira, Hugo ;
Coenye, Tom ;
Azeredo, Joana ;
Melo, Luis D. R. ;
Crabbe, Aurelie .
BIOFILM, 2023, 6
[2]   Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters [J].
Barr, Jeremy J. ;
Auro, Rita ;
Sam-Soon, Nicholas ;
Kassegne, Sam ;
Peters, Gregory ;
Bonilla, Natasha ;
Hatay, Mark ;
Mourtada, Sarah ;
Bailey, Barbara ;
Youle, Merry ;
Felts, Ben ;
Baljon, Arlette ;
Nulton, Jim ;
Salamon, Peter ;
Rohwer, Forest .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (44) :13675-13680
[3]   Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients [J].
Chang, Rachel Yoon Kyung ;
Das, Theerthankar ;
Manos, Jim ;
Kutter, Elizabeth ;
Morales, Sandra ;
Chan, Hak-Kim .
AAPS JOURNAL, 2019, 21 (03)
[4]  
CysticFibrosisFoundation, 2019, Cystic Fibrosis Foundation Patient Registry Annual Data Report 2018
[5]   Exploiting phage-antibiotic synergies to disrupt Pseudomonas aeruginosa PAO1 biofilms in the context of orthopedic infections [J].
De Soir, Steven ;
Paree, Hortence ;
Kamarudin, Nur Hidayatul Nazirah ;
Wagemans, Jeroen ;
Lavigne, Rob ;
Braem, Annabel ;
Merabishvili, Maya ;
De Vos, Daniel ;
Pirnay, Jean-Paul ;
Van Bambeke, Francoise .
MICROBIOLOGY SPECTRUM, 2024, 12 (01)
[6]   In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Pseudomonas aeruginosa from Patients with Cystic Fibrosis [J].
Fiscarelli, Ersilia Vita ;
Rossitto, Martina ;
Rosati, Paola ;
Essa, Nour ;
Crocetta, Valentina ;
Di Giulio, Andrea ;
Lupetti, Veronica ;
Di Bonaventura, Giovanni ;
Pompilio, Arianna .
MICROORGANISMS, 2021, 9 (03) :1-19
[7]   Targeting of Mammalian Glycans Enhances Phage Predation in the Gastrointestinal Tract [J].
Green, Sabrina, I ;
Liu, Carmen Gu ;
Yu, Xue ;
Gibson, Shelley ;
Salmen, Wilhem ;
Rajan, Anubama ;
Carter, Hannah E. ;
Clark, Justin R. ;
Song, Xuezheng ;
Ramig, Robert F. ;
Trautner, Barbara W. ;
Kaplan, Heidi B. ;
Maresso, Anthony W. .
MBIO, 2021, 12 (01) :1-18
[8]   Worldwide rates of diagnosis and effective treatment for cystic fibrosis [J].
Guo, Jonathan ;
Garratt, Anna ;
Hill, Andrew .
JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (03) :456-462
[9]   Activity of Antibiotics against Pseudomonas aeruginosa in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: I nfluence of the Culture Medium [J].
Iglesias, Yvan Diaz ;
Van Bambeke, Francoise .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (04)
[10]   Activity of Antibiotics against Staphylococcus aureus in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium [J].
Iglesias, Yvan Diaz ;
Wilms, Tobias ;
Vanbever, Rita ;
Van Bambeke, Francoise .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (07)